| Phase 3 |
| NCT07818083 |
The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of… |
Ruptured Intracranial Aneurysms |
Not Yet Recruiting |
2026-09-14 |
| Phase 2/3 |
| NCT07209878 |
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With… |
Prostate Cancer (Adenocarcinoma) |
Recruiting |
2025-10-07 |
| Phase 2 |
| NCT07562438 |
Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic… |
Prostate Cancer |
Recruiting |
2026-05-01 |
| NCT06791083 |
Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant… |
Gastric Cancer |
Recruiting |
2025-01-24 |
| NCT07771764 |
A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as… |
ALK-positive Non Small Cell Lung Cancer |
Not Yet Recruiting |
2026-08-18 |
| Phase 1/2 |
| NCT07363382 |
The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer |
Prostate Cancer (Adenocarcinoma) |
Recruiting |
2026-01-23 |
| NCT07363486 |
Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant… |
Prostate Cancer |
Recruiting |
2026-01-23 |
| NCT07056790 |
Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and… |
Prostate CA |
Recruiting |
2025-07-09 |
| NCT07117760 |
Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic… |
Prostate Cancer |
Active, Not Recruiting |
2026-04-29 |
| Phase 1 |
| NCT06181032 |
A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary… |
Biliary Tract Malignancies |
Recruiting |
2024-04-30 |
| NCT07681141 |
Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies |
Patients With Advanced Metastatic FAP-Positive Tumors |
Active, Not Recruiting |
2026-07-02 |
| Early Phase 1 |
| NCT04499365 |
68Ga-FAPI PET/CT in Patients With Various Types of Cancer |
Tumor |
Recruiting |
2026-07-21 |
| NCT04504526 |
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in… |
Lymphoma |
Recruiting |
2026-07-21 |
| NCT06995976 |
Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73 |
Malignant Tumour |
Recruiting |
2025-05-30 |
| NCT06740240 |
68Ga-FAPI-Biotin PET/CT in Patients With Various Types of Cancer |
Tumor |
Recruiting |
2024-12-18 |
| NCT06734572 |
18F-FAPIBiotin PET/CT: Dosimetry and Biodistribution Study |
Malignant Neoplasm |
Recruiting |
2024-12-16 |
| NCT06438250 |
68Ga-JH04 PET/CT: Dosimetry and Biodistribution Studies |
Malignant Neoplasm |
Recruiting |
2024-11-14 |
| NCT06688188 |
68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study |
Malignant Neoplasm |
Recruiting |
2024-11-14 |
| NCT06688305 |
68Ga-NI-FAPI PET/CT: First-in-human Study |
Malignant Neoplasm |
Recruiting |
2024-11-14 |
| NCT06636617 |
177Lu-JH04 in Patients with FAP-Positive Tumors |
Patients with Advanced Metastatic FAP-Positive Tumors |
Recruiting |
2024-10-10 |
| NCT06612580 |
68Ga-AAZTA-NI-093 PET/CT: First-in-human Study |
Prostate Cancer (Adenocarcinoma) |
Recruiting |
2024-09-25 |
| Not applicable |
| NCT07632131 |
Preventive Narrative Exposure Intervention for PTSD in ICU Patients After Cardiopulmonary… |
Cardiopulmonary Bypass |
Recruiting |
2026-09-22 |
| NCT05188872 |
Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of… |
Positron-Emission Tomography |
Recruiting |
2026-07-21 |
| NCT06421142 |
FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer |
Urinary Bladder Neoplasms |
Recruiting |
2026-06-01 |
| NCT06923657 |
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy |
Prostate Cancer Screening |
Recruiting |
2026-05-28 |